Table 1.
N
|
Sex
|
Age (months)
|
Days Since Weaning
|
Sequences Per Sample
|
Prevotella Abundance
|
|
---|---|---|---|---|---|---|
Weaning Study | ||||||
Day 1 | 11 | 4 F, 7 M | 7.0 ± 0.3 | 1.0 ± 0.0 | 2914 ± 326 | 11.0% ± 1.6% |
2 Week | 11 | 4 F, 7 M | 7.5 ± 0.3 | 14.0 ± 0.0 | 2778 ± 238 | 8.4% ± 1.2% |
Cross-Sectional Studies | ||||||
|
||||||
454-Amplicon Pyrosequencing | ||||||
1st Quartile | 8 | 6 F, 2 M | 8.0 ± 0.8 | 18.0 ± 4.3 | 2994 ± 970 | 9.1% ± 3.0% |
2nd Quartile | 8 | 5 F, 3 M | 7.4 ± 0.3 | 16.5 ± 3.5 | 2676 ± 1462 | 12.5% ± 0.5% |
3rd Quartile | 8 | 6 F, 2 M | 7.9 ± 0.8 | 15.9 ± 2.7 | 3589 ± 1312 | 14.0 ± 0.5 |
4th Quartile | 9 | 3 F, 6 M | 7.6 ± 0.4 | 17.4 ± 2.7 | 2707 ± 836 | 17.5% ± 2.1% |
Illumina MiSeq | ||||||
1st Quartile | 7 | 4 F, 3 M | 8.1 ± 0.7 | 16.0 ± 2.0 | 2866 ± 143 | 6.3% ± 0.9% |
2nd Quartile | 7 | 3 F, 4 M | 7.6 ± 0.4 | 14.3 ± 2.2 | 2778 ± 248 | 8.3% ± 0.4 |
3rd Quartile | 8 | 5 F, 3 M | 8.3 ± 0.5 | 17.7 ± 1.5 | 2748 ± 207 | 9.3% ± 0.4 |
4th Quartile | 8 | 3 F, 5 M | 7.6 ± 0.6 | 17.4 ± 2.1 | 2383 ± 327 | 10.9% ± 1.3% |
Means and standard deviations